Posted by: Sandra Moran in: ● November 30, 2011
In my blog post last month I covered a few of the lessons learned by early BPM adopters on how to begin a business process management (BPM) initiative. Based on many early BPM successes, we have seen the focus of BPM projects shift from just streamlining and improving a few key processes within their organization [...]
Posted by: Ethan Smith in: ● July 26, 2011
It’s no secret that Life Sciences is one of the most highly regulated industries with ever-increasing obligations and scrutiny. As these requirements increase it is essential that you are prepared for changes that you can expect will continue to come. Life Sciences companies should build into their operational structure a plan for continuous change and [...]
Posted by: Process Matters Blogger in: ● July 19, 2011
Regulatory Document Submission is one of the most time consuming, yet critical steps pharmaceutical, biotechnology and medical device companies must take to meet government requirements, ensure patient safety, and get a new product introduced to the market. While it is essential to the health of a pharmaceutical company to get its submissions issued efficiently, many [...]
Posted by: Process Matters Blogger in: ● October 5, 2010
Metastorm customers are continuing to receive tons of recognition for their business process improvement initiatives! Last week Metastorm announced that the City of Richmond, VA has received multiple awards for its CommonCents initiative built on Metastorm BPM® software platform. Today, Metastorm announced that our valued customer AmerisourceBergen has been named runner-up in the 2010 Business [...]
Posted by: Ethan Smith in: ● September 8, 2010
Among the litany of headlines recently blasting pharmaceutical, biotech and medical device companies, Allergan – the makers of Botox – has been the latest scapegoat. The past week’s news has been full of stories relating to Allergan’s agreement to settle “off label promotion” charges to the tune of $600M. While the specifics of pleas and [...]
Posted by: Process Matters Blogger in: ● January 18, 2010
A recent study from IDC shows that pharmaceutical manufacturers will lose an estimated 11 billion dollars through channel inefficiencies this year. According to the corresponding release this number is “the equivalent to total revenue for a top 20 pharma simply disappearing each year.”
